Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2022 Filed Dec 20, 2022 01:01 UTC |
Sugrue StephenChief Compliance Officer
|
GrantOptions to purchase Common Stock · Derivative | 250 | $0.00 Strike: $6.93 | $0.00 |
DisclosureSEC source: 0001213900-22-081110 · ownership.xml · derivative · entry 1 Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2032-12-15 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock. F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 15, 2023 through December 15, 2025, in each case, subject to the terms of the Plan. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 01:01 UTC |
Smedra IraDirector
|
GrantCommon Stock | 46,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-081109 · ownership.xml · nonDerivative · entry 1 Smedra Ira · CIK 0001892208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,176 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 06:09 UTC |
TRAVERS JAMES MDirector
|
GrantRestricted Stock Units · Derivative | 23,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-081131 · ownership.xml · derivative · entry 1 TRAVERS JAMES M · CIK 0001258177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,088 Underlying: Common Stock · 23,088 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units ("RSUs") were granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") and will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. F1 · derivative.exercise_date: The restricted stock units ("RSUs") were granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") and will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. F1 · derivative.expiration_date: The restricted stock units ("RSUs") were granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") and will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 23:54 UTC |
Leite EtalvinaDirector
|
GrantStock Option (right to buy) · Derivative | 81,425 | $0.00 Strike: $7.13 | $0.00 |
DisclosureSEC source: 0001213900-22-074320 · ownership.xml · derivative · entry 1 Leite Etalvina · CIK 0001825203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,425 Underlying: Common Stock · 81,425 shares Expires 2032-11-17 F1 · shares: Represents stock options granted under the DocGo Inc. 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock. F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the terms of the Plan. Read SEC document |
| November 04, 2022 Filed Dec 23, 2022 09:15 UTC |
TRAVERS JAMES MDirector
|
Disposition to issuerCommon Stock | 7,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-082394 · ownership.xml · nonDerivative · entry 2 TRAVERS JAMES M · CIK 0001258177 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Travers Holdings LLC Disclosed balance after: 516,028 F3 · shares: Pursuant to Section 3.2(c)(i) of the Stock Escrow Agreement, dated August 15, 2021, by and among Issuer, Motion Acquisition LLC, and Continental Stock Transfer & Trust Company (as assigned from time to time), on November 4, 2022, Travers Holdings LLC forfeited 7,131 shares of Common Stock for no consideration. F2 · ownership.nature: Securities are held by Travers Holdings LLC. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein. Read SEC document |
| November 04, 2022 Filed Dec 23, 2022 14:12 UTC |
Burdiek Michael JDirector
|
Disposition to issuerCommon Stock | 6,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-082392 · ownership.xml · nonDerivative · entry 2 Burdiek Michael J · CIK 0001324293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,561 F2 · shares: Pursuant to Section 3.2(c)(i) of the Stock Escrow Agreement, dated August 15, 2021, by and among Issuer, Motion Acquisition LLC, and Continental Stock Transfer & Trust Company (as assigned from time to time), on November 4, 2022, Mr. Burdiek forfeited 6,986 shares of Common Stock for no consideration. Read SEC document |
| September 16, 2022 Filed Dec 23, 2022 09:15 UTC |
TRAVERS JAMES MDirector
|
Exercise / conversionWarrants to purchase Common Stock · Derivative | 443,432 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001213900-22-082394 · ownership.xml · derivative · entry 3 TRAVERS JAMES M · CIK 0001258177 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Travers Holdings LLC Disclosed balance after: 0 Underlying: Common Stock · 99,019 shares Expires 2026-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior Issuer's redemption of warrants, Travers Holdings LLC exercised its 443,432 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement. F1 · price: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior Issuer's redemption of warrants, Travers Holdings LLC exercised its 443,432 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement. F2 · ownership.nature: Securities are held by Travers Holdings LLC. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein. Read SEC document |
| September 16, 2022 Filed Dec 23, 2022 09:15 UTC |
TRAVERS JAMES MDirector
|
GrantCommon Stock | 99,019 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-082394 · ownership.xml · nonDerivative · entry 1 TRAVERS JAMES M · CIK 0001258177 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Travers Holdings LLC Disclosed balance after: 523,159 F1 · shares: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior Issuer's redemption of warrants, Travers Holdings LLC exercised its 443,432 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement. F1 · price: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior Issuer's redemption of warrants, Travers Holdings LLC exercised its 443,432 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement. F2 · ownership.nature: Securities are held by Travers Holdings LLC. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein. Read SEC document |
| September 16, 2022 Filed Dec 23, 2022 14:12 UTC |
Burdiek Michael JDirector
|
Exercise / conversionWarrants to purchase Common Stock · Derivative | 434,437 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001213900-22-082392 · ownership.xml · derivative · entry 3 Burdiek Michael J · CIK 0001324293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 97,010 shares Expires 2026-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior to the redemption of warrants, Mr. Burdiek exercised his 434,437 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement. F1 · price: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior to the redemption of warrants, Mr. Burdiek exercised his 434,437 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement. Read SEC document |
| September 16, 2022 Filed Dec 23, 2022 14:12 UTC |
Burdiek Michael JDirector
|
GrantCommon Stock | 97,010 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-082392 · ownership.xml · nonDerivative · entry 1 Burdiek Michael J · CIK 0001324293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512,547 F1 · shares: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior to the redemption of warrants, Mr. Burdiek exercised his 434,437 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement. F1 · price: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior to the redemption of warrants, Mr. Burdiek exercised his 434,437 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement. Read SEC document |
| July 27, 2022 Filed Jul 28, 2022 07:05 UTC |
TRAVERS JAMES MDirector
|
OtherWarrants to purchase Common Stock · Derivative | 443,432 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001213900-22-042181 · ownership.xml · derivative · entry 2 TRAVERS JAMES M · CIK 0001258177 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Travers Holdings LLC Disclosed balance after: 443,432 Underlying: Common Stock · 443,432 shares Expires 2026-12-05 F1 · kind: On July 27, 2022, Motion Sponsor LLC ("Sponsor") made a pro rata distribution of shares of Issuer common stock and private placement warrants to acquire shares of Issuer common stock to its member and interest holders. As part of this distribution, Travers Holdings LLC ("Travers Holdings"), a member and interest holder of Sponsor, received 424,140 shares of Issuer and 443,432 private placement warrants to acquire 443,432 shares of Issuer. F2 · ownership.nature: Securities are held by Travers Holdings. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein. Read SEC document |
| July 27, 2022 Filed Jul 28, 2022 07:05 UTC |
TRAVERS JAMES MDirector
|
OtherCommon Stock | 424,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-042181 · ownership.xml · nonDerivative · entry 1 TRAVERS JAMES M · CIK 0001258177 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Travers Holdings LLC Disclosed balance after: 424,140 F1 · kind: On July 27, 2022, Motion Sponsor LLC ("Sponsor") made a pro rata distribution of shares of Issuer common stock and private placement warrants to acquire shares of Issuer common stock to its member and interest holders. As part of this distribution, Travers Holdings LLC ("Travers Holdings"), a member and interest holder of Sponsor, received 424,140 shares of Issuer and 443,432 private placement warrants to acquire 443,432 shares of Issuer. F2 · ownership.nature: Securities are held by Travers Holdings. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein. Read SEC document |
| July 27, 2022 Filed Jul 28, 2022 11:05 UTC |
Burdiek Michael JDirector
|
OtherWarrants to purchase Common Stock · Derivative | 434,437 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001213900-22-042182 · ownership.xml · derivative · entry 2 Burdiek Michael J · CIK 0001324293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,437 Underlying: Common Stock · 434,437 shares Expires 2026-12-05 F1 · kind: On July 27, 2022, Motion Sponsor LLC ("Sponsor") made a pro rata distribution of shares of Issuer common stock and private placement warrants to acquire shares of Issuer common stock to its member and interest holders. As part of this distribution, Mr. Burdiek, a member and interest holder of Sponsor, received 415,537 shares of Issuer and 434,437 private placement warrants to acquire 434,437 shares of Issuer. Read SEC document |
| July 27, 2022 Filed Jul 28, 2022 11:05 UTC |
Burdiek Michael JDirector
|
OtherCommon Stock | 415,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-042182 · ownership.xml · nonDerivative · entry 1 Burdiek Michael J · CIK 0001324293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,537 F1 · kind: On July 27, 2022, Motion Sponsor LLC ("Sponsor") made a pro rata distribution of shares of Issuer common stock and private placement warrants to acquire shares of Issuer common stock to its member and interest holders. As part of this distribution, Mr. Burdiek, a member and interest holder of Sponsor, received 415,537 shares of Issuer and 434,437 private placement warrants to acquire 434,437 shares of Issuer. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:21 UTC |
Capone AnthonyPresident
|
Exercise / conversionOptions to purchase Common Stock · Derivative | 645,145 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001213900-22-037684 · ownership.xml · derivative · entry 4 Capone Anthony · CIK 0001884688 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 645,145 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options became fully exercisable on January 23, 2022 with an expiration date of January 22, 2027. On July 1, 2022, Mr. Capone exercised options to purchase 645,145 shares of common stock for $2.26 a share. In connection with the exercise of the options, the Company withheld 89,767 shares to satisfy his tax withholding obligation upon the exercise and 201,102 shares to cover the exercise price. F1 · derivative.expiration_date: These options became fully exercisable on January 23, 2022 with an expiration date of January 22, 2027. On July 1, 2022, Mr. Capone exercised options to purchase 645,145 shares of common stock for $2.26 a share. In connection with the exercise of the options, the Company withheld 89,767 shares to satisfy his tax withholding obligation upon the exercise and 201,102 shares to cover the exercise price. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:21 UTC |
Capone AnthonyPresident
|
Tax withholdingCommon Stock | 201,102 | $7.26 | $1,460,000.52 |
DisclosureSEC source: 0001213900-22-037684 · ownership.xml · nonDerivative · entry 3 Capone Anthony · CIK 0001884688 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,276 F1 · kind: These options became fully exercisable on January 23, 2022 with an expiration date of January 22, 2027. On July 1, 2022, Mr. Capone exercised options to purchase 645,145 shares of common stock for $2.26 a share. In connection with the exercise of the options, the Company withheld 89,767 shares to satisfy his tax withholding obligation upon the exercise and 201,102 shares to cover the exercise price. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:21 UTC |
Capone AnthonyPresident
|
Tax withholdingCommon Stock | 89,767 | $7.26 | $651,708.42 |
DisclosureSEC source: 0001213900-22-037684 · ownership.xml · nonDerivative · entry 2 Capone Anthony · CIK 0001884688 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,378 F1 · kind: These options became fully exercisable on January 23, 2022 with an expiration date of January 22, 2027. On July 1, 2022, Mr. Capone exercised options to purchase 645,145 shares of common stock for $2.26 a share. In connection with the exercise of the options, the Company withheld 89,767 shares to satisfy his tax withholding obligation upon the exercise and 201,102 shares to cover the exercise price. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:21 UTC |
Capone AnthonyPresident
|
Exercise / conversionCommon Stock | 645,145 | $2.26 | $1,458,027.70 |
DisclosureSEC source: 0001213900-22-037684 · ownership.xml · nonDerivative · entry 1 Capone Anthony · CIK 0001884688 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 645,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 21:22 UTC |
Sugrue StephenChief Compliance Officer
|
GrantOptions to purchase Common Stock · Derivative | 50,000 | $0.00 Strike: $7.26 | $0.00 |
DisclosureSEC source: 0001213900-22-037686 · ownership.xml · derivative · entry 1 Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-07-01 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock. F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on July 1 of each of 2023, 2024, 2025 and 2026, subject to the terms of the Plan. Read SEC document |
| April 28, 2022 Filed May 2, 2022 18:38 UTC |
Merlin Mark DOCMO (Ambulnz Holdings, LLC)
|
GrantOptions to purchase Common Stock · Derivative | 64,515 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001213900-22-023285 · ownership.xml · derivative · entry 1 Merlin Mark DO · CIK 0001884702 · CMO (Ambulnz Holdings, LLC) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,515 Underlying: Common Stock · 64,515 shares Expires 2032-04-28 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock. Read SEC document |
| April 28, 2022 Filed May 2, 2022 22:39 UTC |
Sugrue StephenChief Compliance Officer
|
GrantOptions to purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001213900-22-023286 · ownership.xml · derivative · entry 1 Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-04-28 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock. F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on January 1 of each of 2023, 2024, 2025 and 2026, subject to the terms of the Plan. Read SEC document |
| April 07, 2022 Filed May 4, 2022 20:38 UTC |
Sugrue StephenChief Compliance Officer
|
Exercise / conversionOption to Buy · Derivative | 16,128 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001213900-22-023979 · ownership.xml · derivative · entry 2 Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,128 shares Expires 2031-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The number of shares subject to this tranche has previously erroneously been reported as 16,129 on a Form 3 filed on March 21, 2022. It should have been reported as 16,128. Therefore, this tranche has been fully exercised. Read SEC document |
| April 07, 2022 Filed May 4, 2022 20:38 UTC |
Sugrue StephenChief Compliance Officer
|
Exercise / conversionCommon Stock | 16,128 | $3.25 | $52,416.00 |
DisclosureSEC source: 0001213900-22-023979 · ownership.xml · nonDerivative · entry 1 Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 28, 2022 Filed Apr 26, 2022 10:07 UTC |
Bienstock LeeChief Operating Officer
|
GrantOption to Buy · Derivative | 100,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001213900-22-021516 · ownership.xml · derivative · entry 3 Bienstock Lee · CIK 0001920525 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock · 100,000 shares Expires not disclosed F3 · derivative.exercise_date: Mr. Bienstock was granted 100,000 options on March 28, 2022 pursuant to the Plan, vesting 100% on March 28, 2023, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock. F3 · derivative.expiration_date: Mr. Bienstock was granted 100,000 options on March 28, 2022 pursuant to the Plan, vesting 100% on March 28, 2023, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock. Read SEC document |
| March 28, 2022 Filed Apr 26, 2022 10:07 UTC |
Bienstock LeeChief Operating Officer
|
GrantOption to Buy · Derivative | 320,122 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001213900-22-021516 · ownership.xml · derivative · entry 2 Bienstock Lee · CIK 0001920525 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,122 Underlying: Common stock · 320,122 shares Expires not disclosed F2 · derivative.exercise_date: Mr. Bienstock was granted 320,122 options on March 28, 2022 pursuant to the Plan, vesting 25% on each of March 28, 2023, March 28, 2024, March 28, 2025 and March 28, 2026, in each case, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock. F2 · derivative.expiration_date: Mr. Bienstock was granted 320,122 options on March 28, 2022 pursuant to the Plan, vesting 25% on each of March 28, 2023, March 28, 2024, March 28, 2025 and March 28, 2026, in each case, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock. Read SEC document |
| March 28, 2022 Filed Apr 26, 2022 10:07 UTC |
Bienstock LeeChief Operating Officer
|
GrantRestricted Stock Unit | 146,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-021516 · ownership.xml · nonDerivative · entry 1 Bienstock Lee · CIK 0001920525 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,853 F1 · shares: Mr. Bienstock was granted 146,853 restricted stock units on March 28, 2022 pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan")., vesting 25% on each of March 28, 2023, March 28, 2024, March 28, 2025 and March 28, 2026. Each restricted stock unit represents the right to receive, upon vesting, one share of Common Stock. Read SEC document |
| December 09, 2021 Filed Jan 27, 2022 17:17 UTC |
Oberholzer Adriaan StephanusChief Financial Officer
|
GrantOptions to purchase Common Stock · Derivative | 356,553 | $0.00 Strike: $8.97 | $0.00 |
DisclosureSEC source: 0001213900-22-004058 · ownership.xml · derivative · entry 1 Oberholzer Adriaan Stephanus · CIK 0001885481 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,553 Underlying: Common Stock · 356,553 shares Expires 2031-12-09 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each cash, subject to the terms of the Plan. Read SEC document |
| December 09, 2021 Filed Jan 27, 2022 16:56 UTC |
Oberholzer Adriaan StephanusChief Financial Officer
|
GrantOptions to purchase Common Stock · Derivative | 356,553 | $0.00 Strike: $8.97 | $0.00 |
DisclosureSEC source: 0001213900-22-004015 · ownership.xml · derivative · entry 1 Oberholzer Adriaan Stephanus · CIK 0001885481 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,553 Underlying: Common Stock · 356,553 shares Expires 2031-12-09 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each case, subject to the terms of the Plan. Read SEC document |
| December 09, 2021 Filed Jan 27, 2022 17:15 UTC |
Capone AnthonyPresident
|
GrantOptions to purchase Common Stock · Derivative | 1,018,932 | $0.00 Strike: $8.97 | $0.00 |
DisclosureSEC source: 0001213900-22-004055 · ownership.xml · derivative · entry 1 Capone Anthony · CIK 0001884688 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018,932 Underlying: Common Stock · 1,018,932 shares Expires 2031-12-09 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each cash, subject to the terms of the Plan. Read SEC document |
| December 09, 2021 Filed Jan 27, 2022 16:55 UTC |
Capone AnthonyPresident
|
GrantOptions to purchase Common Stock · Derivative | 1,018,932 | $0.00 Strike: $8.97 | $0.00 |
DisclosureSEC source: 0001213900-22-004013 · ownership.xml · derivative · entry 1 Capone Anthony · CIK 0001884688 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018,932 Underlying: Common Stock · 1,018,932 shares Expires 2031-12-09 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each case, subject to the terms of the Plan. Read SEC document |
| December 09, 2021 Filed Jan 27, 2022 17:32 UTC |
ROSENBERG NORMANCFO (Ambulnz Holdings, LLC)
|
GrantOptions to purchase Common Stock · Derivative | 205,097 | $0.00 Strike: $8.97 | $0.00 |
DisclosureSEC source: 0001213900-22-004078 · ownership.xml · derivative · entry 1 ROSENBERG NORMAN · CIK 0001439758 · CFO (Ambulnz Holdings, LLC) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,097 Underlying: Common Stock · 205,097 shares Expires 2031-12-09 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each cash, subject to the terms of the Plan. Read SEC document |
| December 09, 2021 Filed Jan 27, 2022 17:06 UTC |
ROSENBERG NORMANCFO (Ambulnz Holdings, LLC)
|
GrantOptions to purchase Common Stock · Derivative | 205,097 | $0.00 Strike: $8.97 | $0.00 |
DisclosureSEC source: 0001213900-22-004036 · ownership.xml · derivative · entry 1 ROSENBERG NORMAN · CIK 0001439758 · CFO (Ambulnz Holdings, LLC) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,097 Underlying: Common Stock · 205,097 shares Expires 2031-12-09 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each case, subject to the terms of the Plan. Read SEC document |
| December 09, 2021 Filed Jan 27, 2022 17:36 UTC |
VASHOVSKY STANLEYDirector · Chief Executive Officer · 10% owner
|
GrantOptions to purchase Common Stock · Derivative | 1,018,932 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004082 · ownership.xml · derivative · entry 1 VASHOVSKY STANLEY · CIK 0001409310 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018,932 Underlying: Common Stock · 1,018,932 shares Expires 2031-12-09 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each cash, subject to the terms of the Plan. Read SEC document |
| December 09, 2021 Filed Jan 27, 2022 17:09 UTC |
VASHOVSKY STANLEYDirector · Chief Executive Officer · 10% owner
|
GrantOptions to purchase Common Stock · Derivative | 1,018,932 | $0.00 Strike: $8.97 | $0.00 |
DisclosureSEC source: 0001213900-22-004041 · ownership.xml · derivative · entry 1 VASHOVSKY STANLEY · CIK 0001409310 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018,932 Underlying: Common Stock · 1,018,932 shares Expires 2031-12-09 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each case, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:28 UTC |
Merlin Mark DOCMO (Ambulnz Holdings, LLC)
|
GrantOptions to purchase Common Stock · Derivative | 1,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004073 · ownership.xml · derivative · entry 1 Merlin Mark DO · CIK 0001884702 · CMO (Ambulnz Holdings, LLC) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each cash, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:03 UTC |
Merlin Mark DOCMO (Ambulnz Holdings, LLC)
|
GrantOptions to purchase Common Stock · Derivative | 1,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004032 · ownership.xml · derivative · entry 1 Merlin Mark DO · CIK 0001884702 · CMO (Ambulnz Holdings, LLC) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each case, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:04 UTC |
Witkowski Michael S.Chief Compliance Officer
|
GrantOptions to purchase Common Stock · Derivative | 1,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004034 · ownership.xml · derivative · entry 1 Witkowski Michael S. · CIK 0001884698 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each case, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:30 UTC |
Witkowski Michael S.Chief Compliance Officer
|
GrantOptions to purchase Common Stock · Derivative | 1,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004075 · ownership.xml · derivative · entry 1 Witkowski Michael S. · CIK 0001884698 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each cash, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:19 UTC |
Fillo ChristopherDirector
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004060 · ownership.xml · derivative · entry 1 Fillo Christopher · CIK 0001884629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:11 UTC |
Fillo ChristopherDirector
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004045 · ownership.xml · derivative · entry 1 Fillo Christopher · CIK 0001884629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:07 UTC |
KATZ STEVENDirector
|
GrantOption to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004038 · ownership.xml · derivative · entry 1 KATZ STEVEN · CIK 0001202928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:24 UTC |
TRAVERS JAMES MDirector
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004069 · ownership.xml · derivative · entry 1 TRAVERS JAMES M · CIK 0001258177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 16:53 UTC |
TRAVERS JAMES MDirector
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004008 · ownership.xml · derivative · entry 1 TRAVERS JAMES M · CIK 0001258177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:34 UTC |
KATZ STEVENDirector
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004080 · ownership.xml · derivative · entry 1 KATZ STEVEN · CIK 0001202928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 22:26 UTC |
Burdiek Michael JDirector
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004071 · ownership.xml · derivative · entry 1 Burdiek Michael J · CIK 0001324293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 22:01 UTC |
Burdiek Michael JDirector
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004029 · ownership.xml · derivative · entry 1 Burdiek Michael J · CIK 0001324293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:20 UTC |
Tendler Ely DDirector · General Counsel and Secretary
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004062 · ownership.xml · derivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 16:58 UTC |
Tendler Ely DDirector · General Counsel and Secretary
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004021 · ownership.xml · derivative · entry 1 Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 22:22 UTC |
Smedra IraDirector
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004065 · ownership.xml · derivative · entry 1 Smedra Ira · CIK 0001892208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 21:59 UTC |
Smedra IraDirector
|
GrantOptions to purchase Common Stock · Derivative | 79,208 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004024 · ownership.xml · derivative · entry 1 Smedra Ira · CIK 0001892208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,208 Underlying: Common Stock · 79,208 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.